1.
Bioorg Med Chem
; 12(9): 1991-4, 2004 May 01.
Article
in English
| MEDLINE
| ID: mdl-15080902
ABSTRACT
A novel series of quinazolino-beta-carbolinone derivatives was synthesized and evaluated for their in vitro and in vivo anticancer activity. Many compounds have shown good in vitro activity in the range 1-8 microM concentration. Three of the compounds were further tested in nude mice bearing HT-29 colon cancer xenografts.
